You are here: Industry Insights > Ibrutinib

News List

The sales of the BTK inhibitor reached at least USD 11 billion worldwide in 2021 PharmaSources/Caicai
March 16, 2022
In today's new drug world, BTK inhibitor stands out as a member of chemical drugs in a context where biologics yield unusually brilliant results.
Zydus Cadila receives tentative approval from USFDA for Ibrutinib expresspharma
July 23, 2021
The drug will be manufactured at the group’s formulation manufacturing facility at the Special Economic Zone (SEZ), Ahmedabad.
Calquence Demonstrates Fewer Incidences of Atrial Fibrillation vs Ibrutinib in Patients with Leukaemia americanpharmaceuticalreview
June 09, 2021
Final results from the head-to-head ELEVATE-RR Phase III trial of AstraZeneca’s Calquence (acalabrutinib) demonstrated non-inferior progression-free survival (PFS) and statistically significantly fewer events of atrial fibrillation versus ibrutinib in ...
Severe Adverse Cardiovascular Events Associated With Ibrutinib drugs
September 27, 2019
Cardiovascular adverse drug reactions (CV-ADR) occur in association with ibrutinib, according to a study published in the issue of the Journal of the American College of Cardiology.
Ibrutinib, Venetoclax Active in High-Risk, Seniors With CLL drugs
May 31, 2019
Ibrutinib, Venetoclax Active in High-Risk, Seniors With CLL.
ASH: Ibrutinib Tops Bendamustine + Rituximab for CLL drugs
December 04, 2018
For older patients with untreated chronic lymphocytic leukemia (CLL), treatment with ibrutinib alone or in combination with rituximab is associated with improved.....
AbbVie, J&J’s Imbruvica fails to target in B-Cell lymphoma trial pharmatimes
July 13, 2018
AbbVie and Johnson & Johnson’s Imbruvica has failed to meet its key target in a late stage study assessing its use in patients with treatment-naïve diffuse large B-cell lymphoma.
Ibrutinib may benefit glioblastoma patients europeanpharmaceuticalreview
June 01, 2018
An FDA-approved drug for lymphoma and leukaemia may also help treat the most common – and deadliest type of brain tumour…